Unnamed stage
$15m
Melbourne biotech Cartherics raises $15m for ovarian cancer stem cell trial
A Melbourne biotechnology firm developing a CAR-NK cell therapy for ovarian cancer has completed a fifteen-million-dollar raise to fund its first trial in humans and work toward other cancers.